BLGO - BIOLARGO, INC.
0.1644
0.000 -0.061%
Share volume: 188,103
Last Updated: 03-26-2026
Chemicals/Chemicals And Allied Products:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.16
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | 03-04-2026 | |
| Total revenue | 4.760 M | 5.014 M | 4.351 M | 3.269 M | 2.777 M | 1.103 M | 616.000 K | |
| Cost of revenue | 2.514 M | 2.877 M | 2.629 M | 1.781 M | 1.356 M | 731.000 K | 491.000 K | |
| Gross profit | 2.246 M | 2.137 M | 1.722 M | 1.488 M | 1.421 M | 372.000 K | 125.000 K | |
| -4.85% | -19.42% | -13.59% | -4.50% | -73.82% | -66.40% | |||
| Operating expenses | 3.009 M | 3.027 M | 2.783 M | 3.350 M | 3.223 M | 3.703 M | 4.085 M | |
| Selling general and admin | 2.225 M | 2.404 M | 2.093 M | 2.559 M | 2.688 M | 3.088 M | 3.433 M | |
| Research and development | 784.000 K | 623.000 K | 690.000 K | 791.000 K | 535.000 K | 615.000 K | 652.000 K | |
| Total expenses | 3.009 M | 3.027 M | 2.783 M | 3.350 M | 3.223 M | 7.552 M | 4.136 M | |
| 0.60% | -8.06% | 20.37% | -3.79% | 134.32% | -45.23% | |||
| Operating income | -763.000 K | -890.000 K | -1.061 M | -1.862 M | -1.802 M | -7.180 M | -4.011 M | |
| Ebit | -763.000 K | -778.000 K | -1.061 M | -1.856 M | -1.802 M | -7.180 M | -4.011 M | |
| Pretax income | -775.000 K | -780.000 K | -1.060 M | -1.921 M | -1.882 M | -7.244 M | -4.142 M | |
| 0.65% | 35.90% | 81.23% | -2.03% | 284.91% | -42.82% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -775.000 K | -780.000 K | -1.060 M | -1.921 M | -1.882 M | -7.244 M | -4.142 M | |
| -0.65% | -35.90% | -81.23% | 2.03% | -284.91% | 42.82% |